skip to main content
Show Results with:

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

The New England journal of medicine, October 7, 2004, Vol.351(15), pp.1502-1512 [Peer Reviewed Journal]

No full-text

Searching Remote Databases, Please Wait